Benztropine-d3 mesylate

Cat. No.: IBDI-433967

Benztropine-d3 (mesylate) is the deuterium labeled Benztropine mesylate. Benztropine mesylate (Benzatropine mesylate) is an orally active centrally acting anticholinergic agent that can be used for Parkinson's disease research. Benztropine mesylate is an anti-histamine agent and a dopamine re-uptake inhibitor. Benztropine mesylate is also a human D2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs (cancer stem cells) effects.

Product Details

Target	Dopamine Receptor | Histamine Receptor | mAChR
Molecular Weight	406.55
SMILES	CS(=O)(O)=O.[2H]C([2H])([2H])N([[email protected]@H](CC1)C2)[[email protected]]1C[[email protected]@H]2OC(C3=CC=CC=C3)C4=CC=CC=C4

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.